Janus Henderson Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15,046	Closed	-$51K	–	1464
2018 Q3	$51K	Buy	15,046 +3,200	+27%	+$10.8K	﹤0.01%	1437
2018 Q2	$45K	Buy	+11,846	New	+$45K	﹤0.01%	1386